Abbott forecasts 6.5%-7.5% 2026 comparable sales growth while integrating Exact Sciences with $0.20 EPS dilution
- Abbott stock slips on guidance cut, ranks 10th in healthcare equipment Quant ratings Seeking Alpha —
- Abbott Laboratories Cuts Outlook, Says Mild Flu Season Hurt Sales Wall Street Journal —
- Abbott trims 2026 profit forecast on Exact deal hit, shares fall - Reuters Reuters —
- Abbott trims 2026 profit forecast on Exact deal hit, shares fall The Globe and Mail —
- Abbott Stock Tumbles on Earnings. Nutrition Business Is Struggling and Merger Costs Biting. Barrons —